GLAXOSMITHKLINE LLC
Patent Owner
Stats
- 503 US PATENTS IN FORCE
- 12 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 503 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 13,202 Total Citation Count
- Nov 02, 1988 Earliest Filing
- 335 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0057,582 METHODS OF TREATMENT OF EOSINOPHILIC BRONCHITIS WITH AN ANTI-IL-5 ANTIBODYNov 06, 17Mar 01, 18[A61K, C07K]
2017/0367,648 METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASSJul 10, 17Dec 28, 17[H01J, G01N, A61B]
2017/0157,113 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITORFeb 17, 17Jun 08, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9907847 Pyrrolopyrimidines as therapeutic agents for the treatment of diseasesDec 06, 16Mar 06, 18[A61K, C07D]
9861627 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorFeb 17, 17Jan 09, 18[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0106,756 BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCERAbandonedDec 21, 15Apr 21, 16[A61K]
2016/0002,273 THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDES AND ANALOGUES AS SIRTUIN MODULATORSAbandonedMar 07, 14Jan 07, 16[C12Q, C07F, C07D]
2015/0322,082 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORSAbandonedNov 22, 13Nov 12, 15[C07D]
2015/0238,507 BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCERAbandonedAug 14, 13Aug 27, 15[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.